Table 4.
Integrin α2β1 | ||||||
---|---|---|---|---|---|---|
n | <20% | ≥20% | p # | |||
Growth Factor-Receptor | ERα | 48 | 0.035 | |||
<1% | 10 | 1 | ||||
≥1% | 20 | 17 | ||||
PR | 48 | 0.127 | ||||
<1% | 22 | 9 | ||||
≥1% | 8 | 9 | ||||
Her-2/neu | 48 | 1 | ||||
negative | 22 | 13 | ||||
positive | 8 | 5 | ||||
EGFR | 48 | 0.027 | ||||
<50% | 27 | 11 | ||||
≥50% | 3 | 7 | ||||
HGFR | 48 | 0.133 | ||||
<50% | 16 | 5 | ||||
≥50% | 14 | 13 | ||||
IGF1R | 48 | 0.451 | ||||
<80% | 4 | 4 | ||||
≥80% | 26 | 14 | ||||
Cell-Adhesion-Molecule | MUC-1 | 48 | 0.765 | |||
<70% | 14 | 7 | ||||
≥70% | 16 | 11 | ||||
CD44v6 | 48 | 0.103 | ||||
<10% | 24 | 10 | ||||
≥10% | 6 | 8 | ||||
Integrin αvβ3 | 48 | 0.19 | ||||
<20% | 24 | 11 | ||||
≥20% | 6 | 7 |
Legend: n: number of patients, #: p-value calculated by Fisher’s exact two-tailed test.